BRANDES INVESTMENT PARTNERS, LP - 31 Mar 2025 SCHEDULE 13G Report for AVADEL PHARMACEUTICALS PLC Common Shares (AVDL)

Filing Manager: BRANDES INVESTMENT PARTNERS, LP
Reporting Manager: BRANDES INVESTMENT PARTNERS, LP
Security: AVADEL PHARMACEUTICALS PLC Common Shares
Symbol: AVDL
Shares outstanding: 96,113,254 shares
Disclosed Ownership: 5,670,682 shares
Ownership: 5.9%
Form type: SCHEDULE 13G
Filing time: 14 May 2025, 13:14:49 UTC
Date of event: 31 Mar 2025
SEC: View on sec.gov

Reporting Managers (1)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
BRANDES INVESTMENT PARTNERS, LP	5.9%	5,670,682	0	3,832,365	/s/ Glenn Carlson	Executive Director